SCHEMBL1632502

SCHEMBL1632502

NS(=O)(=O)c1ccc(Nc2ncc3cccc(CNCC4CCCO4)c3n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ TNK2 Q07912 8/20 0.45
▸ CDK2 P24941 3/20 0.44
▸ CCNA2 P20248 1/20 0.44
▸ CCNA1 P78396 1/20 0.44
▸ PKM P14618 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ KCNH3 Q9ULD8 1/20 0.41
▸ IKBKB O14920 2/20 0.41
▸ SYK P43405 2/20 0.41
▸ CDK1 P06493 2/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA4 P22748 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ CCNT1 O60563 1/20 0.40
▸ CCNB1 P14635 1/20 0.40
▸ CDK7 P50613 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632503 0.80 CDK2 (0.46) CDK2CCNA2IKBKBSYKCDK1
SCHEMBL1632121 0.80 SYK (0.45) CDK2IKBKBSYKCDK1CCNE1
SCHEMBL13498245 0.80 CDK2 (0.48) CDK2CCNA2CCNA1IKBKBCDK1
SCHEMBL1634500 0.79 SYK (0.49) CDK2CCNA2CCNA1IKBKBSYK
SCHEMBL1633586 0.78 CA1 (0.51) CDK2IKBKBSYKCDK1CA1
SCHEMBL1633321 0.77 CA1 (0.48) CDK2CCNA2IKBKBCDK1CCNE1
SCHEMBL1632328 0.77 CA2 (0.50) CDK2CCNA2CCNA1IKBKBCDK1
SCHEMBL16453393 0.77 TNK2 (0.75) TNK2CDK2SYKCDK1CCNE1
SCHEMBL1633835 0.76 IKBKB (0.47) CDK2CCNA2IKBKBCDK1CCNE1
Hydrochloric Acid SCHEMBL16445900 0.76 TNK2 (0.74) ALDH1A1TNK2CDK2CDK1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback